All treatments
Treatment
Trastuzumab Deruxtecan (T-DXd) clinical trials
3 indexed studies · 2 currently recruiting
- RecruitingPHASE2
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
This study looks at new treatments for stomach or food pipe cancer that can be removed by surgery. It aims to see how safe and effective these new drugs or drug combinations are before and after the operation.
For: Gastroesophageal AdenocarcinomaUnited States · Canada · China - Active not recruitingPHASE3
DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
This study compares two treatments, trastuzumab deruxtecan and trastuzumab emtansine (T-DM1), for advanced HER2-positive breast cancer. It looks at how well they work and if they are safe for patients who have already had certain other treatments.
For: Breast CancerUnited States · Australia · Belgium - RecruitingPHASE1, PHASE2
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
This study tests a new drug, AZD9574, alone and with other treatments, for people with advanced cancers. It aims to see how safe it is, how the body handles it, and if it helps shrink tumours.
For: Advanced Solid MalignanciesUnited States · Australia · Germany